DITROPAN

This brand name is authorized in Austria, Australia, Canada, Spain, France, Malta, Poland, United Kingdom, United States, South Africa

Active ingredients

The drug DITROPAN contains one active pharmaceutical ingredient (API):

1 Oxybutynin hydrochloride UNII L9F3D9RENQ - OXYBUTYNIN CHLORIDE

Oxybutynin acts as a competitive antagonist of acetylcholine at post-ganglionic muscarinic receptors, resulting in relaxation of bladder smooth muscle. Read about Oxybutinin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G04BD04	Oxybutynin	G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BD Urinary antispasmodics
Discover more medicines within G04BD04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 8039D
Country: CA	Health Products and Food Branch	Identifier(s): 02243960, 02243961
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 57185
Country: FR	Base de données publique des médicaments	Identifier(s): 69224470
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 143229, 19922, 19940, 381290
Country: MT	Medicines Authority	Identifier(s): AA908/18101
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100019812, 100261163, 100284158, 100354893, 100379835
Country: US	FDA, National Drug Code	Identifier(s): 50458-805, 50458-810
Country: ZA	Health Products Regulatory Authority	Identifier(s): L/5.4/104